Joe Amabile Resumes Routine Three Weeks After Brain Tumor Surgery

Key points

• Joe Amabile, 40, underwent surgery in early August to remove a 'blueberry-sized' astrocytoma in his left frontal lobe.
• The tumor was discovered in July during an elective full-body MRI screening, preventing a potential seizure.
• Dr. Alexandra Miller of the Perlmutter Cancer Center described the prognosis as good due to the early detection.
• Amabile is currently taking daily medication and reports being 90% recovered, with some lingering speech challenges.
• He resumed running 15 days post-surgery and emphasizes the importance of sharing his experience on social media.
• His wife, Serena Pitt, has been by his side, noting that the experience has deepened their gratitude for their partnership.

Background

In July 2026, Amabile first revealed the diagnosis after an MRI screening, noting the lesion was likely a glioma. This follows a trend of reality stars, such as Busy Philipps, using full-body MRI screenings to detect early-stage brain tumors. The current recovery update comes three weeks after his surgery, marking a significant step in his return to normal routines.

How outlets are covering it

ABC News and SurvivorNet both highlight Amabile’s positive outlook and the successful outcome of the surgery. ABC News emphasizes the medical details provided by Dr. Alexandra Miller, noting the 'good prognosis' and the specific type of tumor, an astrocytoma. SurvivorNet focuses more on Amabile’s emotional resilience, quoting his vow to 'turn this into the best thing ever.' While both sources agree on the successful surgery and early detection, ABC News provides more clinical context regarding the tumor's nature, whereas SurvivorNet centers the narrative on his mental attitude and public advocacy.

Why it matters

This case highlights the value of elective full-body MRI screenings in detecting early-stage brain tumors, potentially preventing severe symptoms like seizures. It also underscores the role of public figures in destigmatizing cancer diagnoses and encouraging early medical intervention through social media advocacy.

What to watch

Amabile will continue his daily medication regimen and regular monitoring. He plans to maintain his public presence to support others with similar diagnoses, while his medical team will monitor for any recurrence or complications related to the astrocytoma.